JPRN-UMIN000000693已完成未知
Phase II study of second-line chemotherapy using CPT-11 plus CDDP in patients with advanced/recurrent gastric cancer (OGSG 0504) - OGSG0504
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)0 个研究点目标入组 35 人开始时间: 2007年5月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. with interstitial pneumonitis or pulmonary fibrosis 2. much fluid in the cavity 3. active double cancer except carcinoma in situ or skin cancer 4. with infectious disease which needs treatment 5. intestinal paralysis or ileus 6. watery stool (diarrhea) 7. uncontrolled DM or DM being treated by insulin 8. with ischemic cardiac disease 9. with psycologic disorder which disturbs recruiting to the study 10. with severe diseases (cardiac failure, liver dysfunction or renal dysfunction) 11. pregnant and/or nursing women 12. present and/or past allergy against medicines 13. doctor's decision not to recruit to the study
研究者
相似试验
招募中
2 期
Phase II study of second line chemotherapy with carboplatin and paclitaxel for metastatic melanomamelanomaJPRN-UMIN000003260Division of Skin Oncology, Comprehensive cancer center, Saitama medical university International medical center40
已完成
不适用
Phase II study of second-line chemotherapy using modified FOLFOX6 in patients with advanced/ recurrent colorectal cancer (OGSG 0505)Patients with unresectable or metastatic colon cancer registant to fluorouracil treatmentJPRN-UMIN000000841OGSG50
尚未招募
1 期
Phase 1/2 study of combination chemotherapy with Carboplatin, nab-Paclitaxel, and Bevacizumab for advanced non-squamous non-small cell lung canceron-squamous Non-small-cell Lung CancerJPRN-UMIN000016735Hiroshima Asa City Hospital35
招募中
2 期
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancerresectable pancreatic cancerJPRN-UMIN000005912Tokai university, school of medicine50
已完成
2 期
Phase II study of combination chemotherapy with cisplatin / pemetrexed / bevacizumab in patients with relapsed nonsquamous non-small cell lung cancerRelapsed nonsquamous non-small cell lung cancerJPRN-UMIN000014291St. Marianna University School of Medicine30